Acurx pharmaceuticals to participate in the a.g.p. biotech and specialty pharma conference october 13, 2021

Staten island, n.y., sept. 29, 2021 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that management will participate in the a.g.p.
ACXP Ratings Summary
ACXP Quant Ranking